Advertisement

Topics

KloudScript™ Specialty Network, Now Dispensing Vosevi™ and Mavyret™

07:00 EDT 8 Aug 2017 | Bio-Medicine

Oakbrook Terrace, IL (PRWEB) August 08, 2017 KloudScript™ is excited to announce the expansion of the Hepatitis C therapeutic category with the latest FDA approved medications Vosevi™ and Mavyret™. Vosevi is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) in...

Original Article: KloudScript™ Specialty Network, Now Dispensing Vosevi™ and Mavyret™

NEXT ARTICLE

More From BioPortfolio on "KloudScript™ Specialty Network, Now Dispensing Vosevi™ and Mavyret™"

Quick Search
Advertisement
 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...